With a growing global population, speeding up drug development timelines is of paramount importance for all pharmaceutical and biotech companies. Thanks to innovative software solutions it’s now possible to make better decisions at each stage of the clinical supply chain.
Some drug overage is always necessary to avoid stockouts that could put patients as risk and impact the success of the trial. Clinical trial wastage rates are currently averaging between 55-75% and the manufacture of unnecessary drug products extends trial timelines.
End-to-end optimization will help clinical supply teams make better decisions that minimize required overage by: